Motor outcomes in patients with advanced Parkinson's disease treated with levodopa/carbidopa intestinal gel in Italy: an interim analysis from the GREENFIELD observational study.

导出 OA

翻译打印收藏纠错

作者： Leonardo,Lopiano ^[1] ; Nicola,Modugno ^[2] ; Pietro,Marano ^[3] ; Mariachiara,Sensi ^[4] ; Giuseppe,Meco ^[5] ; Antonino,Cannas ^[6] ; Graziano,Gusmaroli ^[7] ; Filippo,Tamma ^[8] ; Francesca,Mancini ^[9] ; Rocco,Quatrale ^[10] ; Anna Maria,Costanzo ^[11] ; Giuliana,Gualberti ^[11] ; Gabriella,Melzi ^[12] ; Umberto,di Luzio Paparatti ^[11] ; Angelo,Antonini ^[13]

作者单位： Department of Neuroscience, University of Torino, Torino, Italy. ^[1] Neurology Department, IRCCS Neuromed, Pozzilli (IS), Italy. ^[2] Neurorehabilitation Unit, Casa di Cura Villa dei Gerani, Catania, Italy. ^[3] Neurology Unit, Hospital Sant'Anna, Ferrara, Italy. ^[4] Department of Neurology and Psychiatry (Parkinson's Centre) and Research Centre of Social Diseases (CIMS), Sapienza University, Rome, Italy. ^[5] Neurology Unit, Policlinico Universitario Monserrato, Cagliari, Italy. ^[6] Neurology Unit, Ospedale degli Infermi, Biella, Italy. ^[7] Neurology Unit, Miulli Hospital, Acquaviva delle Fonti (BA), Italy. ^[8] Parkinson Disease and Movement Disorders Centre, Neurology Unit, S.Pio X Clinic, Milan, Italy. ^[9] Neurology Unit, Hospital dell'Angelo, Mestre (VE), Italy. ^[10] AbbVie Srl, Campoverde (LT), Italy. ^[11] AbbVie Srl, Campoverde (LT), Italy. gabriella.melzi@abbvie.com. ^[12] Parkinson and Movement Disorder Unit, IRCCS Hospital San Camillo, Venice, Italy. ^[13]

关键词 Advanced Parkinson’s disease Intestinal infusion Levodopa–carbidopa Motor symptoms Quality of life Routine patient care